0
0
April 8, 2026
NEW DELHI — In a significant boost for decentralized healthcare, the Indian Council of Medical Research (ICMR) has formally backed HemoQR, a low-cost, smartphone-based haemoglobin screening tool developed at IIT Kharagpur. The endorsement, announced this week, paves the way for the portable device to be deployed across rural health centers and community camps, offering a potential breakthrough in the early detection of anaemia—a condition that currently affects over half of India’s women and children.
The Technology: From Finger-Prick to Phone Screen
Developed by SmartQR Technologies under the mentorship of Professor Suman Chakraborty, Director of IIT Kharagpur, HemoQR reimagines the traditional laboratory-based blood test. The process is designed for simplicity and speed: a health worker collects a single finger-prick blood sample, applies it to a specialized paper strip, and uses a smartphone camera to capture the image.
Within minutes, the HemoQR software analyzes the color intensity and provides an estimated haemoglobin level. Unlike conventional methods that require expensive hematology analyzers, steady electricity, and highly trained technicians, HemoQR is a point-of-care (POC) tool meant for field use.
Initial testing of the device was conducted at VMMC & Safdarjung Hospital in New Delhi, focusing on its efficacy as a primary screening mechanism. By moving the “lab” to the patient’s bedside or a village community hall, health officials hope to slash the time between testing and the initiation of treatment.
A Persistent Public Health Challenge
The urgency behind HemoQR’s development is rooted in sobering statistics. Despite decades of government interventions like the Anaemia Mukt Bharat (Anaemia Free India) program, the condition remains stubbornly prevalent.
According to a comprehensive 2025 systematic review published in BMC Public Health, the burden of anaemia in India remains a critical concern across all age groups:
-
72% of pregnant women.
-
69% of toddlers under the age of three.
-
53% of adults aged 19–59.
“Anaemia is not just a number on a lab report; it is a barrier to national development,” says a representative from the World Health Organization (WHO), noting that the condition reduces physical work capacity in adults and impairs cognitive development in children. For pregnant women, untreated anaemia significantly increases the risk of low birth weight and maternal complications.
Examining the Evidence
The ICMR’s support follows several rounds of clinical evaluation. While full peer-reviewed data from the latest large-scale trials are still emerging, secondary reports indicate that HemoQR has been assessed on cohorts ranging from 200 to 500 patient samples.
In these studies, the device’s results were compared against “gold-standard” laboratory hematology analyzers. The findings suggested that HemoQR is a “promising” method for rapid screening, particularly in resource-limited settings where traditional venipuncture (drawing blood from a vein) is impractical.
However, medical experts emphasize a critical distinction: screening is not a definitive diagnosis. > “A screening tool like HemoQR is designed to catch the ‘red flags’ in a large population quickly,” explains Dr. Aruna Singh, an independent hematologist not involved in the study. “If a person screens positive for low haemoglobin, they still require a clinical evaluation to determine the cause—whether it’s iron deficiency, a vitamin B12 gap, chronic infection, or an inherited disorder like thalassemia.”
Strategic Implications for India
The integration of HemoQR into the national health framework aligns with the government’s push for “Aatmanirbhar” (self-reliant) medical technology. By reducing the cost per test and removing the need for a cold chain or heavy machinery, the tool could be a game-changer for frontline ASHA workers and Primary Health Centres (PHCs).
Key Advantages for Public Health:
-
Cost-Effectiveness: Significantly cheaper than traditional lab tests.
-
Portability: Can be carried in a small kit to remote hilly or tribal regions.
-
Immediate Results: Enables health workers to provide nutritional counseling or supplements on the spot rather than waiting days for lab results.
Limitations and the Road Ahead
Despite the optimism, HemoQR faces hurdles. All screening devices carry a risk of false positives (indicating anaemia when it isn’t there) or false negatives (missing the condition). The accuracy of smartphone-based tests can also be affected by ambient lighting conditions or the quality of the phone’s camera sensor, though the developers claim their software accounts for these variables.
Furthermore, the success of the tool depends on a robust referral pathway. Identifying an anaemic patient in a remote village is only the first step; the healthcare system must then ensure that the patient has access to the necessary iron supplements, dietary interventions, or specialist care required to treat the underlying cause.
Conclusion: A New Era for Screening?
As India enters the mid-point of 2026, the backing of HemoQR by the ICMR represents a pivotal moment in the fight against “the silent killer.” If the tool survives the rigors of large-scale, real-world deployment, it could serve as a global model for how mobile technology can bridge the gap in healthcare equity.
For the average citizen, the message is clear: while technology is making it easier to monitor our health, a rapid test is the beginning of a conversation with a doctor, not the end of it.
References
- https://health.economictimes.indiatimes.com/news/diagnostics/icmr-backs-iit-kharagpur-developed-hemoqr-for-quick-anaemia-screening/130073883?utm_source=latest_news&utm_medium=homepage
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
